RTTNews | Oct 23, 2020 07:05AM EDT

07:05 Friday, October 23, 2020 (RTTNews) - Kezar Life Sciences Announces Orphan Drug Designations For KZR-616 For Polymyositis And Dermatomyositis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved